Iowanews Headlines

Press Release

Paroxysmal Nocturnal Hemoglobinuria Market Size is projected to grow at a CAGR of 7.1% by 2034, estimates DelveInsight

DelveInsight’s “Paroxysmal Nocturnal Hemoglobinuria Market Insights, Epidemiology, and Market Forecast – 2034” report delivers an in-depth understanding of the Paroxysmal Nocturnal Hemoglobinuria, historical and forecasted epidemiology and the Paroxysmal Nocturnal

Read Full Article

AGC Biologics “TTHX-1114” Market size expansion of Several Folds by 2034

Explore DelveInsight’s comprehensive report on TTHX-1114 (AGC Biologics), featuring market landscape, sales forecast, and market size analysis through 2034.   [Las Vegas, United States] DelveInsight, a leader in healthcare research

Read Full Article

Hidradenitis Suppurativa Market Size in the 7MM was ~USD ~1,400 Million in 2023 and It is expected to grow by 2034, estimates DelveInsight

DelveInsight’s “Hidradenitis Suppurativa Market Insight, Epidemiology, and Market Forecast – 2034” report delivers an in-depth understanding of hidradenitis suppurativa, historical and forecasted epidemiology, as well as the hidradenitis suppurativa market

Read Full Article

Cystinosis Market Size in the 7MM is projected to grow at a significant CAGR by 2034, estimates DelveInsight

DelveInsight’s “Cystinosis Market Insights, Epidemiology, and Market Forecast – 2034” report delivers an in-depth understanding of the Cystinosis, historical and forecasted epidemiology and the Cystinosis market trends in the United

Read Full Article

Nonalcoholic Steatohepatitis Market to Evolve Rapidly Over the Next Decade, DelveInsight Observes | Madrigal Pharmaceuticals, Novo Nordisk, 89bio

Nonalcoholic Steatohepatitis Diagnostics Market Insights, Epidemiology, and Market Forecast-2034 The Key Nonalcoholic Steatohepatitis Companies in the market include – Madrigal

Read Full Article

Polymyalgia Rheumatica Treatment Market Size in the 7MM is projected to grow by 2034, estimates DelveInsight

DelveInsight’s “Polymyalgia Rheumatica Market Insights, Epidemiology, and Market Forecast – 2034” report delivers an in-depth understanding of the Polymyalgia Rheumatica,

Read Full Article

Hemophilia B Pipeline 2025: Therapies Under Investigation, Clinical Trials Milestones, and FDA Approvals by DelveInsight | Novo Nordisk, Sanofi, Pfizer, Belief BioMed, Centessa Pharmaceuticals

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Hemophilia B pipeline constitutes 15+ key companies continuously working towards

Read Full Article

Appy Pie Achieves Industry Milestone with 2026 Capterra Award for Application Development

Commenting on the achievement, Abhinav Girdhar, Founder & CEO of Appy Pie, said, “Being recognized by Capterra and earning the

Read Full Article

Pulmonary Arterial Hypertension Pipeline 2025: FDA Updates, Therapy Innovations, and Clinical Trial Landscape Analysis by DelveInsight | Ribomic, Gmax Biopharm, Novartis, Cereno Scientific AB, Insmed

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Pulmonary Arterial Hypertension pipeline constitutes 55+ key companies continuously working

Read Full Article

Gorlin Syndrome Clinical Trial Pipeline Shows Potential with Active Contributions from 5+ Key Companies | DelveInsight

DelveInsight’s, “Gorlin Syndrome Pipeline Insight, 2025” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Gorlin Syndrome

Read Full Article

Categories